49–008 

109TH CONGRESS REPORT " ! HOUSE OF REPRESENTATIVES 2d Session 109–387 

PROVIDING FOR CONSIDERATION OF H.R. 2829, OFFICE 

OF NATIONAL DRUG CONTROL POLICY REAUTHORIZATION ACT OF 2005 

MARCH 8, 2006.—Referred to the House Calendar and ordered to be printed 

Mr. SESSIONS, from the Committee on Rules, 

submitted the following 

R E P O R T 

[To accompany H. Res. 713] 

The Committee on Rules, having had under consideration House 

Resolution 713, by a nonrecord vote, report the same to the House 

with the recommendation that the resolution be adopted. 

SUMMARY OF PROVISIONS OF THE RESOLUTION

The resolution provides for the consideration of H.R. 2829, the 

Office of National Drug Control Policy Reauthorization Act of 2005, 

under a structured rule. The rule provides one hour of general debate equally divided and controlled by the chairman and ranking 

minority member of the Committee on Government Reform. The 

rule waives all points of order against consideration of the bill. 

The rule provides that the amendment in the nature of a substitute recommended by the Committee on the Judiciary now printed in the bill shall be considered as an original bill for the purpose 

of amendment and shall be considered as read. The rule waives all 

points of order against the committee amendment in the nature of 

a substitute. 

The rule makes in order only those amendments printed in this 

report. The rule provides that the amendments made in order may 

be offered only in the order printed in this report, may be offered 

only by a Member designated in this report, shall be considered as 

read, shall be debatable for the time specified in this report equally 

divided and controlled by the proponent and an opponent, shall not 

be subject to amendment, and shall not be subject to a demand for 

division of the question in the House or in the Committee of the 

Whole. The rule waives all points of order against the amendments 

printed in this report. 


ccoleman on PROD1PC71 with HEARING
2 

Finally, the rule provides one motion to recommit with or without instructions. 

EXPLANATION OF WAIVERS

The waiver of all points of order against consideration of the bill 

is necessary because the reports of both the Committee on Government Reform and the Committee on the Judiciary fail to meet the 

requirements of clause 3(c)(4) of rule XIII, requiring a statement of 

general performance goals and objectives. The waiver of all points 

of order against the committee amendment in the nature of a substitute is necessary because the committee amendment contains 

provisions in violation of clause 4 of rule XXI, prohibiting appropriations on legislative bills. The manager’s amendment offered by 

Mr. Souder of Indiana, if adopted, would remedy the violations of 

clause 4 of rule XXI. 

COMMITTEE VOTES

Pursuant to clause 3(b) of House rule XIII the results of each 

record vote on an amendment or motion to report, together with 

the names of those voting for and against, are printed below: 

Rules Committee record vote No. 148 

Date: March 8, 2006. 

Measure: H.R. 2829, Office of National Drug Control Policy Reauthorization Act of 2005. 

Motion by: Mrs. Slaughter. 

Summary of motion: To make in order and provide the appropriate waivers for the amendment offered by Rep. Bean which requires the GAO to conduct a study on the unintended affects of the 

illegal use, trade, and distribution of medications for the attention 

deficit hyperactivity disorder, such as Adderall and Ritalin, among 

college students. 

Results: Defeated 2 to 6. 

Vote by Members: Hastings (WA)—Nay; Sessions—Nay; Capito—

Nay; Cole—Nay; Bishop—Nay; Gingrey—Nay; Slaughter—Yea; 

McGovern—Yea. 

SUMMARY OF AMENDMENTS MADE IN ORDER

(Summaries derived from information provided by sponsors.) 

1. Souder (IN): Manager’s Amendment. Makes technical and conforming changes to account for changes in law within the jurisdiction of those Committees that waived formal business meetings on 

the bill. Strikes the mandatory restrictions on certification of budgets related to enforcement in certain contexts of the ‘‘Drug Free 

Student Loan’’ provision. (10 minutes) 

2. Baird (WA)/Hooley (OR)/Cardoza (CA): Directs the Director of 

ONDCP, in consultation with other federal agencies, to convene an 

international summit on the threat of methamphetamine and synthetic drug precursor chemicals. The Director shall do so to intensify and coordinate an effective international response along with 

other affected countries in order to prevent methamphetamine production and precursor diversion. Provides that the Director must 

carry out the amendment within 12 months from the enactment of 


ccoleman on PROD1PC71 with HEARING
3 

the bill. Provides an authorization of $1 million for this purpose. 

(10 minutes) 

3. Boozman (AR): Ensures that the effects of illicit drug abuse on 

children of substance abusers are considered in the annual National Drug Control Strategy. Requires ONDCP to conduct a study 

and the President to report to Congress on drug court programs 

that conduct hearings in nontraditional public places, such as 

schools. (10 minutes) 

4. Chabot (OH)/Cannon (UT)/Boswell (IA)/Calvert (CA)/Larsen 

(WA): Commissions studies on: State Drug Endangered Children 

programs focusing on meth and report back to Congress within 6 

months with recommendations for a Nat. Drug Endangered Children policy; Comparing state precursor control laws and report 

back to Congress within 6 months with a list of best practices with 

respect to such laws. Creates an Internet Meth Clearing House to 

provide current info to, and to facilitate info sharing among, Fed, 

State, and local agencies about meth trafficking, abuse, treatment, 

and abuse prevention. Commissions a report on: what schools have 

initiated drug testing among those schools attending ONDCP conferences on drug testing; the meth epidemic, detailing the spread 

of meth usage broken down by three-digit zip code based on industrial and school drug tests and clandestine lab seizures; who received performance bonuses at ONDCP and for how much from October 2004 until the present. Mandates the ONDCP Synthetic Drug 

Action Plan be reported to Congress by 3/31/06. (20 minutes) 

5. Cuellar (TX): Directs the ONDCP to conduct a study of the 

incidences of kidnapped, killed, and missing Americans along the 

U.S.-Mexico border and report to Congress on how to prevent such 

crimes. (10 minutes) 

6. Filner (CA): Instructs the ONDCP to develop a strategy to 

combat border tunnels for drug trafficking and to recommend to 

Congress a criminal penalty for digging or using border tunnels for 

such acts. (10 minutes) 

7. Graves (MO): Requires the ONDCP to submit a report to Congress explaining its participation in and support of a conference addressing harm reduction in methamphetamine abuse, not prevention. Additionally, ONDCP must explain what management and reporting systems ONDCP will change to ensure that the Administration is more supportive of efforts fighting the methamphetamine 

epidemic. (10 minutes) 

8. Hooley (OR): Requires ONDCP to submit to Congress a comprehensive strategy that addresses the increased threat from methamphetamine and includes interdiction and precursor chemical 

controls, demand reduction, treatment and efforts to prevent the 

diversion of precursor chemicals on an international level. (10 minutes) 

9. Jackson-Lee (TX): Requires the ONDCP to perform an assessment of illicit drug and alcohol use by children, and appropriate 

intervention methods. Requires ONDCP to report to Congress on 

its assessment. The amendment specifies items to assess that were 

not considered by the National Survey on Drug Use and Health, 

such as the role of Federal, state, and local criminal justice systems 

in providing intervention. (10 minutes) 

10. Lungren (CA): Requires the Director of ONDCP to provide for 

a program that advises states on establishing laws and policies to 


ccoleman on PROD1PC71 with HEARING
4 

address alcohol and other drug issues, as well as drafting and revising model state drug laws. Authorizes $1,500,000 for each of fiscal years 2007 through 2011 for that purpose. (10 minutes) 

11. Lynch (MA): Directs the ONDCP to request the Institute of 

Medicine of the National Academy of Sciences to enter into an 

agreement under which the Institute agrees to conduct a study on 

iatrogenic addiction associated with oxycodone hydrochloride controlled-release tablets and directs the ONDCP to report to Congress 

on the study. (10 minutes) 

12. Paul (TX): Provides that the act shall not be in effect after 

September 30, 2011. (10 minutes) 

13. Rehberg (MT)/Boozman (AR)/King (IA)/Capito (WV)/Souder 

(IN)/Graves (MO): Ensures that no less than 10% of national media 

campaign funds will be expended on advertisements specifically intended to reduce methamphetamine use. Grants the Director the 

authority to award grants to private entities producing researchbased public service messages, with the goal of reducing first-time 

meth use among young people. Funds may be redirected if domestic 

meth lab seizures decrease by at least 75% from the 2006 level. (10 

minutes) 

14. Renzi (AZ): Directs the ONDCP to report to Congress on the 

representation of tribal governments in High Intensity Drug Trafficking Areas Program and in high intensity drug trafficking areas 

designated under that program. The report shall include a list of 

tribal governments represented, an explanation of the rationale for 

the level of representation, and recommendations by the director 

for the methods for increasing the number of tribal governments 

represented in the Program. (10 minutes) 

15. Terry (NE): Directs the ONDCP to consult with the head of 

each major national organization that represents law enforcement 

officers, agencies, or associations, prior to making recommendations 

to the President on the national budget for drug control and enforcement each year. (10 minutes) 

TEXT OF AMENDMENTS MADE IN ORDER UNDER THE RULE 

1. AN AMENDMENT TO BE OFFERED BY REPRESENTATIVE SOUDER OF

INDIANA, OR HIS DESIGNEE, DEBATABLE FOR 10 MINUTES

Page 145, strike lines 3 through 9. 

Page 145, line 10, strike ‘‘(vi)’’ and insert ‘‘(v)’’. 

Page 145, line 15, strike ‘‘(vii)’’ and insert ‘‘(vi)’’. 

Page 146, line 5, strike ‘‘(viii)’’ and insert ‘‘(vii)’’. 

Page 148, line 19, strike ‘‘(g)’’ and insert ‘‘(h)’’. 

Page 149, line 7, strike ‘‘(h)’’ and insert ‘‘(i)’’. 

Page 149, strike lines 9 through 18 and insert the following: 

(1) by amending subsection (g) to read as follows: 

‘‘(g) INAPPLICABILITY TO CERTAIN PROGRAMS.—The provisions of 

this section shall not apply to the National Intelligence Program, 

the Joint Military Intelligence Program, and Tactical and Related 

Activities unless such program or an element of such program is 

designated as a National Drug Control Program—

‘‘(1) by the President; or 

‘‘(2) jointly by—

‘‘(A) in the case of the National Intelligence Program, the 

Director and the Director of National Intelligence; or 


ccoleman on PROD1PC71 with HEARING
5 

‘‘(B) in the case of the Joint Military Intelligence Program and Tactical and Related Activities, the Director, the 

Director of National Intelligence, and the Secretary of Defense. ’’; and 

(2) by amending subsection (h) to read as follows: 

‘‘(h) CONSTRUCTION.—Nothing in this Act shall be construed as 

derogating the authorities and responsibilities of the Director of 

National Intelligence or the Director of the Central Intelligence 

Agency contained in the National Security Act of 1947 (50 U.S.C. 

401 et seq.), the Central Intelligence Agency Act of 1949 (50 U.S.C. 

403a et seq.), or any other law.’’. 

Page 149, line 19, strike ‘‘(i)’’ and insert ‘‘(j)’’. 

Page 151, line 14, strike ‘‘(j)’’ and insert ‘‘(k)’’. 

Page 153, line 3, strike ‘‘(k)’’ and insert ‘‘(l)’’. 

Page 158, line 7, strike ‘‘(l)’’ and insert ‘‘(m)’’. 

Page 160, line 14, strike ‘‘(m)’’ and insert ‘‘(n)’’. 

Page 183, line 18, strike ‘‘The’’ and insert the following: ‘‘Subject 

to the availability of appropriations, the’’. 

Page 187, line 22, insert after ‘‘Director’’ the following: ‘‘, in consultation with the Director of National Intelligence,’’. 

Page 202, line 12, strike ‘‘No’’ and insert the following: ‘‘Subject 

to the availability of appropriations, no’’. 

Page 204, line 21, strike ‘‘For’’ and insert the following: ‘‘Subject 

to the availability of approprations, for’’. 

Page 217, strike lines 14 through 19, and insert the following: 

Director, the Director of National Intelligence, or the head of any 

Federal Government agency the activities of which are described in 

the plan, would be detrimental to the law enforcement or national 

security activities of any Federal, State, or local agency, shall be 

presented to Congress separately from the rest of the report. 

2. AN AMENDMENT TO BE OFFERED BY REPRESENTATIVE BAIRD OF

WASHINGTON, OR HIS DESIGNEE, DEBATABLE FOR 10 MINUTES

At the end of the bill, add the following new section (and conform 

the table of contents accordingly): 

SEC. 20. INTERNATIONAL SUMMIT ON METHAMPHETAMINE THREAT. 

(a) SUMMIT REQUIREMENT.—The Director of the Office of National Drug Control Policy in the Executive Office of the President 

shall, in consultation with the Secretary of State, the Attorney 

General, the Secretary of Homeland Security, the Secretary of 

Health and Human Services, and the United States Trade Representative, seek to convene an international summit on the threat 

of methamphetamine and synthetic drug precursor chemicals. 

(b) PARTICIPATION OF OTHER COUNTRIES.—The Director shall 

seek to convene the summit with the participation and involvement 

of government leaders at the highest level from all countries that 

are direct sources of precursor chemicals and from all countries 

that are affected by methamphetamine production, trafficking, and 

use, to intensify and coordinate an effective international response 

in order to prevent methamphetamine production and precursor diversion. 

(c) INTERNATIONAL AGREEMENTS.—The Director shall encourage 

the negotiation, drafting, and ratification of multilateral or bilatVerDate Aug 31 2005 06:13 Mar 09, 2006 Jkt 049008 PO 00000 Frm 00005 Fmt 6659 Sfmt 6602 E:\HR\OC\HR387.XXX HR387

ccoleman on PROD1PC71 with HEARING
6 

eral agreements that may contain information-sharing treaties concerning provisions for precursor importation and exportation and 

additional provisions for annual assessments of medical and scientific needs of each signatory country. 

(d) MATTERS ADDRESSED BY THE SUMMIT.—The summit may address the following: 

(1) The greater involvement of international policing and 

customs organizations, such as Interpol, the United Nations 

Office on Drugs and Crime, and the World Customs Organization. 

(2) Expanding resources and hired persons to track international shipments of ephedrine, pseudoephedrine, and other 

precursor substances as controlled by the International Narcotics Control Board. 

(3) Working with the private sector and Federal agencies, as 

well as the World Health Organization, to support the research 

and development of substances that can effectively replace primary precursors used in the manufacture of synthetic drugs. 

(e) DEADLINE.—The Director shall seek to convene the summit 

not later than 12 months after the date of the enactment of this 

Act and follow-up summits in subsequent years as the Director 

finds necessary. 

(f) AUTHORIZATION OF APPROPRIATIONS.—There are authorized to 

be appropriated to the Director $1,000,000 to carry out this section. 

3. AN AMENDMENT TO BE OFFERED BY REPRESENTATIVE BOOZMAN

OF ARKANSAS, OR HIS DESIGNEE, DEBATABLE FOR 10 MINUTES

Page 168, line 17, strike ‘‘and’’. 

Page 168, line 19, strike the period at the end and insert ‘‘; and’’. 

Page 168, after line 19, insert the following: 

‘‘(IV) the effect of illicit drug use on children of 

substance abusers. 

Page 170, line 12, insert after ‘‘drug use’’ the following: ‘‘(including the effects on children of substance abusers)’’. 

At the end of the bill add the following new section (and conform 

the table of contents accordingly): 

SEC. 20. STUDY ON DRUG COURT HEARINGS IN NONTRADITIONAL 

PLACES. 

(a) FINDING.—Congress finds that encouraging drug courts and 

schools to enter into partnerships that allow students to see the repercussions of drug abuse by non-violent offenders may serve as a 

strong deterrent and promote demand reduction. 

(b) STUDY.—The Director of the Office of National Drug Control 

Policy shall conduct a study on drug court programs that conduct 

hearings in nontraditional public places, such as schools. At a minimum, the study shall evaluate similar programs in operation, such 

as the program operated in the Fourth Judicial District Drug 

Court, in Washington County, Arkansas. 

(c) REQUIREMENT.—At the same time the President submits to 

Congress the National Drug Control Strategy due February 1, 

2007, pursuant to section 706 of the Office of National Drug Control Policy Reauthorization Act of 1998, the President shall submit 

to Congress a report on the study conducted under subsection (b). 


ccoleman on PROD1PC71 with HEARING
7 

The report shall include an evaluation of the results of the study 

and such recommendations as the President considers appropriate. 

(d) DEMAND REDUCTION.—In this section, the term ‘‘demand reduction’’ has the meaning provided in section 702(1) of the Office 

of National Drug Control Policy Reauthorization Act of 1998 (21 

U.S.C. 1701(1)). 

4. AN AMENDMENT TO BE OFFERED BY REPRESENTATIVE CHABOT OF

OHIO, OR HIS DESIGNEE, DEBATABLE FOR 20 MINUTES

Page 161, after line 2, insert the following: 

(n) REQUIREMENT TO SUBMIT NATIONAL SYNTHETIC DRUGS AC- TION STRATEGY.—Not later than 120 days after the date of the enactment of this Act, the Director of National Drug Control Policy 

shall submit to Congress the National Synthetic Drugs Action 

Strategy outlined in the National Synthetic Drugs Action Plan submitted by the Director in October 2004. 

(o) REQUIREMENT FOR STUDY OF STATE PRECURSOR CHEMICAL

CONTROL LAWS.— (1) STUDY.—The Director of National Drug Control Policy 

shall conduct a study of State laws with respect to precursor 

chemical controls. 

(2) REPORT.—Not later than six months after the date of the 

enactment of this Act, the Director of National Drug Control 

Policy shall submit a report to Congress on the results of the 

study under paragraph (1), including— (A) a comparison of the State laws studied and the effectiveness of each such law; and 

(B) a list of best practices observed with respect to such 

laws. 

(p) REQUIREMENT FOR STUDY OF DRUG ENDANGERED CHILDREN

PROGRAMS.— (1) STUDY.—The Director of National Drug Control Policy 

shall conduct a study of methamphetamine-related activities 

that are conducted by different Drug Endangered Children programs administered by States. 

(2) REPORT.—Not later than six months after the date of the 

enactment of this Act, the Director of National Drug Control 

Policy shall submit to Congress a report on the results of the 

study under paragraph (1). Such report shall include—

(A) an analysis of the best practices of the activities 

studied; and 

(B) recommendations for establishing a national policy to 

address drug endangered children, based on the Drug Endangered Children programs administered by States. 

(3) DEFINITIONS.—In this subsection—

(A) the term ‘‘methamphetamine-related activity’’ means 

any activity related to the production, use, or effects of 

methamphetamine; and 

(B) the term ‘‘drug endangered children’’ means children 

whose physical, mental, or emotional health are at risk because of the production, use, or effects of methamphetamine by another person. 

At the end of the bill, add the following new sections (and conform the table of contents accordingly): 


ccoleman on PROD1PC71 with HEARING
8 

SEC. 20. NATIONAL METHAMPHETAMINE INFORMATION CLEARINGHOUSE. 

(a) SHORT TITLE.—This Act may be cited as the ‘‘National Methamphetamine Information Clearinghouse Act of 2005’’. 

(b) DEFINITIONS.—In this section—

(1) the term ‘‘Council’’ means the National Methamphetamine Advisory Council established under subsection (c)(2)(A); 

(2) the term ‘‘drug endangered children’’ means children 

whose physical, mental, or emotional health are at risk because of the production, use, or effects of methamphetamine by 

another person; 

(3) the term ‘‘National Methamphetamine Information Clearinghouse’’ or ‘‘NMIC’’ means the information clearinghouse established under subsection (c)(1); and 

(4) the term ‘‘qualified entity’’ means a State or local government, school board, or public health, law enforcement, nonprofit, or other nongovernmental organization providing services related to methamphetamine. 

(c) ESTABLISHMENT OF CLEARINGHOUSE AND ADVISORY COUNCIL.—

(1) CLEARINGHOUSE.—There is established, under the supervision of the Director of National Drug Control Policy, an information clearinghouse to be known as the National Methamphetamine Information Clearinghouse. 

(2) ADVISORY COUNCIL.—

(A) IN GENERAL.—There is established an advisory council to be known as the National Methamphetamine Advisory Council. 

(B) MEMBERSHIP.—The Council shall consist of 10 members appointed by the Director of National Drug Control 

Policy—

(i) not fewer than three of whom shall be representatives of law enforcement agencies; 

(ii) not fewer than four of whom shall be representatives of nongovernmental and nonprofit organizations 

providing services related to methamphetamine; and 

(iii) one of whom shall be a representative of the Department of Health and Human Services. 

(C) PERIOD OF APPOINTMENT; VACANCIES.—Members 

shall be appointed for three years. Any vacancy in the 

Council shall not affect its powers, but shall be filled in 

the same manner as the original appointment. 

(d) NMIC REQUIREMENTS AND REVIEW.— (1) IN GENERAL.—The NMIC shall promote sharing information regarding successful law enforcement, treatment, environmental, social services, and other programs related to the production, use, or effects of methamphetamine and grants available for such programs. 

(2) COMPONENTS.—The NMIC shall include—

(A) a toll-free number; and 

(B) a website that—

(i) provides information on the short-term and longterm effects of methamphetamine use; 

(ii) provides information regarding methamphetamine treatment programs and programs for drug enVerDate Aug 31 2005 06:13 Mar 09, 2006 Jkt 049008 PO 00000 Frm 00008 Fmt 6659 Sfmt 6602 E:\HR\OC\HR387.XXX HR387

ccoleman on PROD1PC71 with HEARING
9 

dangered children, including descriptions of successful 

programs and contact information for such programs; 

(iii) provides information regarding grants for methamphetamine-related programs, including contact information and links to websites; 

(iv) allows a qualified entity to submit items to be 

posted on the website regarding successful public or 

private programs or other useful information related 

to the production, use, or effects of methamphetamine; 

(v) includes a restricted section that may only be 

accessed by a law enforcement organization that contains successful strategies, training techniques, and 

other information that the Council determines helpful 

to law enforcement agency efforts to combat the production, use or effects of methamphetamine; 

(vi) allows public access to all information not in a 

restricted section; and 

(vii) contains any additional information the Council 

determines may be useful in combating the production, use, or effects of methamphetamine. 

(3) REVIEW OF POSTED INFORMATION.—

(A) IN GENERAL.—Not later than 30 days after the date 

of submission of an item by a qualified entity, the Council 

shall review an item submitted for posting on the website 

described in paragraph (2)(B)—

(i) to evaluate and determine whether the item, as 

submitted or as modified, meets the requirements for 

posting; and 

(ii) in consultation with the Director of National 

Drug Control Policy, to determine whether the item 

should be posted in a restricted section of the website. 

(B) DETERMINATION.—Not later than 45 days after the 

date of submission of an item, the Council shall—

(i) post the item on the website described in paragraph (2)(B); or 

(ii) notify the qualified entity that submitted the 

item regarding the reason such item shall not be posted and modifications, if any, that the qualified entity 

may make to allow the item to be posted. 

(4) AUTHORIZATION OF APPROPRIATIONS.—There are authorized to be appropriated—

(A) for fiscal year 2007—

(i) $1,000,000 to establish the NMIC and Council; 

and 

(ii) such sums as are necessary for the operation of 

the NMIC and Council; and 

(B) for each of fiscal years 2008 through 2011, such 

sums as are necessary for the operation of the NMIC and 

Council. 

SEC. 21. REPORT ON SCHOOL DRUG TESTING. 

(a) REPORT REQUIREMENT.—The Director of National Drug Control Policy shall prepare a report on drug testing in schools. The 

report shall include a list of secondary schools that have initiated 

drug testing from among those schools that have attended conVerDate Aug 31 2005 06:13 Mar 09, 2006 Jkt 049008 PO 00000 Frm 00009 Fmt 6659 Sfmt 6602 E:\HR\OC\HR387.XXX HR387

ccoleman on PROD1PC71 with HEARING
10 

ferences on drug testing sponsored by the Office of National Drug 

Control Policy. 

(b) DEADLINE.—Not later than 120 days after the date of the enactment of this Act, the Director of National Drug Control Policy 

shall submit to Congress the report required under subsection (a). 

SEC. 22. REPORT ON METHAMPHETAMINE EPIDEMIC. 

(a) REPORT REQUIREMENT.—The Director of National Drug Control Policy shall prepare a report on methamphetamine usage in 

the United States. The report shall describe the usage by zip code 

based on information obtained from industrial and school drug testing and seizures of clandestine laboratories. 

(b) DEADLINE.—Not later than 120 days after the date of the enactment of this Act, the Director of National Drug Control Policy 

shall submit to Congress the report required under subsection (a). 

SEC. 23. REPORT ON ONDCP PERFORMANCE BONUSES. 

(a) REPORT REQUIREMENT.—The Director of National Drug Control Policy shall prepare a report on performance bonuses at the 

Office of National Drug Control Policy. The report shall include a 

list of employees who received performance bonuses, and the 

amount of such bonuses, for the period beginning on October 1, 

2004, and ending on the date of submission of the report. 

(b) DEADLINE.—Not later than 120 days after the date of the enactment of this Act, the Director of National Drug Control Policy 

shall submit to Congress the report required under subsection (a). 

5. AN AMENDMENT TO BE OFFERED BY REPRESENTATIVE CUELLAR

OF TEXAS, OR HIS DESIGNEE, DEBATABLE FOR 10 MINUTES

Page 161, after line 2, insert the following: 

(n) STUDY OF PERSONS KIDNAPPED, KILLED, AND MISSING ALONG

THE BORDER BETWEEN THE UNITED STATES AND MEXICO.—

(1) IN GENERAL.—The Director of National Drug Control Policy shall study the specific impact on citizens of the United 

States of violence related to drug-trafficking along the international border between the United States and Mexico. 

(2) REPORT.—Not later than 180 days after the date of the 

enactment of this Act, and annually thereafter, the Director of 

National Drug Control Policy shall submit to Congress a report, including recommendations on methods to solve the offenses described in such paragraph and to reduce the occurrence of such offenses. 

(3) AUTHORIZATION OF APPROPRIATIONS.—There is authorized 

to be appropriated to carry out this subsection $1,000,000 for 

each of fiscal years 2007 through 2011. 

6. AN AMENDMENT TO BE OFFERED BY REPRESENTATIVE FILNER OF

CALIFORNIA, OR HIS DESIGNEE, DEBATABLE FOR 10 MINUTES

Page 159, after line 5, insert the following new paragraph (and 

redesignate subsequent paragraphs accordingly): 

(3) SPECIFIC CONTENT RELATED TO DRUG TUNNELS BETWEEN

THE UNITED STATES AND MEXICO.—The Southwest Border 

Counternarcotics Strategy shall include—


ccoleman on PROD1PC71 with HEARING
11 

(A) a strategy to end the construction and use of tunnels 

and subterranean passages that cross the international 

border between the United States and Mexico for the purpose of illegal trafficking of drugs across such border; and 

(B) recommendations for criminal penalties for persons 

who construct or use such a tunnel or subterranean passage for such a purpose. 

7. AN AMENDMENT TO BE OFFERED BY REPRESENTATIVE GRAVES OF

MISSOURI, OR HIS DESIGNEE, DEBATABLE FOR 10 MINUTES

At the end of the bill, add the following new section (and conform 

the table of contents accordingly): 

SEC. 20. REPORT ON GOVERNMENT-SPONSORED METHAMPHETAMINE 

CONFERENCE. 

(a) REPORT.—Not later than 30 days after the date of the enactment of this Act, the Director of the Office of National Drug Control Policy shall submit to Congress a report explaining the rationale and circumstances leading to the sponsorship by the Department of Health and Human Resources, and the participation by 

employees of such department, in a conference conducted by the 

Harm Reduction Coalition and the Harm Reduction Project on August 19th and 20th, 2005, in Salt Lake City, Utah, titled the ‘‘1st 

National Conference on Methamphetamine, HIV, and Hepatitis 

Science & Response’’. 

(b) ADDITIONAL MATTERS COVERED.—The report shall include a 

description of the management and reporting systems of the Office 

of National Drug Control Policy that are in place or that will be 

put in place to ensure that the policy of the Federal Government 

is consistently supportive of efforts to prevent the use of methamphetamine. 

8. AN AMENDMENT TO BE OFFERED BY REPRESENTATIVE HOOLEY OF

OREGON, OR HER DESIGNEE, DEBATABLE FOR 10 MINUTES

Page 161, after line 2, insert the following new subsection: 

(n) REQUIREMENT FOR METHAMPHETAMINE STRATEGY.—

(1) IN GENERAL.—Not later than 90 days after the date of the 

enactment of this Act, the Director of the Office of National 

Drug Control Policy shall submit to Congress a comprehenisve 

strategy that addresses the increased threat from methamphetamine. 

(2) MATTERS COVERED.—The strategy shall include—

(A) interdiction and precursor chemical controls; 

(B) demand reduction and treatment; 

(C) alternative development programs; 

(D) efforts to prevent the diversion of precursor chemicals on an international level; and 

(E) an assessment of the specific level of funding and resources necessary to significantly reduce the production 

and trafficking of methamphetamine. 

(3) TREATMENT OF CLASSIFIED OR LAW ENFORCEMENT SENSITIVE INFORMATION.—Any content of the strategy that involves 

information classified under criteria established by an ExecuVerDate Aug 31 2005 06:13 Mar 09, 2006 Jkt 049008 PO 00000 Frm 00011 Fmt 6659 Sfmt 6602 E:\HR\OC\HR387.XXX HR387

ccoleman on PROD1PC71 with HEARING
12 

tive order, or whose public disclosure, as determined by the Director or the head of any relevant Federal agency, would be 

detrimental to the law enforcement or national security activities of any Federal, foreign, or international agency, shall be 

presented to Congress separately from the rest of the strategy. 

9. AN AMENDMENT TO BE OFFERED BY REPRESENTATIVE JACKSONLEE OF TEXAS, OR HER DESIGNEE, DEBATABLE FOR 10 MINUTES

Section 6 is amended by adding at the end the following new 

subsection: 

(n) REQUIREMENT FOR AN ASSESSMENT OF ILLICIT DRUG AND ALCOHOL USE BY CHILDREN, AND APPROPRIATE INTERVENTION METHODS.—

(1) IN GENERAL.—The Director of National Drug Control Policy shall complete an assessment of report materials, studies, 

and statistics with respect to the 5-year period before the date 

of enactment of this Act, to determine the extent to which children who are 12 to 17 years of age—

(A) experiment with and regularly use marijuana, alcohol, cigarettes, prescription drugs without a prescription, 

designer drugs (such as ecstasy), and other illicit drugs 

(such as cocaine); and 

(B) have access to intervention services or programs, including drug testing, counseling, rehabilitation, legal representation, and other services or programs associated 

with prevention, treatment, and punishment of substance 

abuse. 

(2) ASSESSMENT PROCEDURE.—In completing the assessment 

under paragraph (1), the Director—

(A) shall consider relevant public health and academic 

research materials and studies, and may also consider relevant statistics concerning illicit drug and alcohol use, and 

criminal convictions related to such use; and 

(B) shall make findings, based on the information considered under subparagraph (A), regarding the nature and 

extent of illicit drug and alcohol use among children who 

are 12 to 17 years of age, and the availability of preventative, intervention, and rehabilitation services and programs to such children. 

(3) REPORT TO CONGRESS.—Not later than 1 year after the 

date of enactment of this Act, the Director shall submit a report to Congress regarding the assessment under this subsection and the findings under paragraph (2)(B). Such report 

shall include, with respect to children who are 12 to 17 years 

of age, the following information: 

(A) Services and programs that have been effective in 

preventing such children from experimenting with and beginning the regular use of illicit drugs and alcohol. 

(B) The extent to which chronic drug and alcohol use occurs in such children. 

(C) The extent to which schools and other public institutions provide intervention for such children who are chronic users of illicit drugs and alcohol, the specific roles such 


ccoleman on PROD1PC71 with HEARING
13 

schools and institutions play, and the extent to which such 

interventions are successful. 

(D) Additional resources schools and other public institutions need to provide successful intervention to such children, including funding. 

(E) The role of Federal agencies in providing intervention to such children who are chronic users of illicit drugs 

and alcohol, and the extent to which Federal agency intervention is successful. 

(F) Additional resources Federal agencies need to provide successful intervention to such children, including 

funding. 

(G) The role of the Federal, State, and local criminal justice systems in providing intervention to such children who 

are chronic users of illicit drugs and alcohol, and the extent to which criminal justice interventions are successful. 

10. AN AMENDMENT TO BE OFFERED BY REPRESENTATIVE LUNGREN

OF CALIFORNIA, OR HIS DESIGNEE, DEBATABLE FOR 10 MINUTES

Page 161, after line 2, insert the following: 

(n) MODEL STATE DRUG LAWS.—

(1) IN GENERAL.—The Director of the Office of National Drug 

Control Policy shall provide for a corporation that is described 

in section 501(c)(3) of the Internal Revenue Code of 1986 and 

exempt from tax under section 501(a) of such Code to—

(A) advise States on establishing laws and policies to address alcohol and other drug issues, based on the model 

State drug laws developed by the President’s Commission 

on Model State Drug Laws in 1993; and 

(B) revise such model State drug laws and draft supplementary model State laws to take into consideration 

changes in the alcohol and drug abuse problems in the 

State involved. 

(2) AUTHORIZATION OF APPROPRIATIONS.—There is authorized 

to be appropriated to carry out this subsection $1,500,000 for 

each of fiscal years 2007 through 2011. 

11. AN AMENDMENT TO BE OFFERED BY REPRESENTATIVE LYNCH OF

MASSACHUSETTS, OR HIS DESIGNEE, DEBATABLE FOR 10 MINUTES

At the end of the bill, add the following (and make such conforming 

changes as may be necessary to the table of contents): 

SEC. 20. STUDY ON PRESCRIPTION DRUGS ASSOCIATED WITH IATROGENIC ADDICTION. 

(a) IN GENERAL.—The Director of the Office of National Drug 

Control Policy shall request the Institute of Medicine of the 

National Academy of Sciences to enter into an agreement 

under which the Institute agrees to conduct a study examining 

certain aspects of prescription drugs associated with iatrogenic 

addiction, including oxycodone hydrochloride controlled-release 

tablets. 

(b) REQUIREMENTS.—The study conducted pursuant to this 

section shall evaluate—


ccoleman on PROD1PC71 with HEARING
14 

(1) the rate and impact of iatrogenic addiction associated 

with the use of prescription drugs described in subsection 

(a); and 

(2) the relative addictiveness of prescription drugs described in subsection (a) when compared with other opioids 

and other substances included in schedule I or II of the 

schedules of controlled substances established by section 

202 of the Controlled Substances Act (21 U.S.C. 812). 

(c) REPORT.—The Director of the Office of National Drug 

Control Policy shall ensure that the agreement under subsection (a) provides for the submission of a report to the Congress, not later than one year after the date of the enactment 

of this Act, on the results of the study conducted pursuant to 

this section. 

12. AN AMENDMENT TO BE OFFERED BY REPRESENTATIVE PAUL OF

TEXAS, OR HIS DESIGNEE, DEBATABLE FOR 10 MINUTES

At the end of the bill, add the following new section (and conform 

the table of contents accordingly): 

SEC. 20. SUNSET. 

After section 716, as redesignated by section 14 of this Act, insert 

the following: 

‘‘SEC. 717. SUNSET. 

‘‘This Act shall not be in effect after September 30, 2011.’’. 

13. AN AMENDMENT TO BE OFFERED BY REPRESENTATIVE REHBERG

OF MONTANA, OR HIS DESIGNEE, DEBATABLE FOR 10 MINUTES

Page 213, after line 6, insert the following new subsection: 

‘‘(k) PREVENTION OF METHAMPHETAMINE ABUSE AND OTHER

EMERGING DRUG ABUSE THREATS.—

‘‘(1) REQUIREMENT TO USE 10 PERCENT OF FUNDS FOR METHAMPHETAMINE ABUSE PREVENTION.—The Director shall ensure 

that, of the amounts appropriated under this section for the 

national media campaign for a fiscal year, not less than 10 percent shall be expended solely for—

‘‘(A) the activities described in subsection (b)(1) with respect to advertisements specifically intended to reduce the 

use of methamphetamine; and 

‘‘(B) grants under paragraph (2). 

‘‘(2) GRANT AUTHORITY.—The Director may award grants to 

private entities for purposes of methamphetamine media 

projects. Any such project—

‘‘(A) shall have as its goal the significant reduction of the 

prevalence of first-time methamphetamine use among 

young people; and 

‘‘(B) shall focus solely on the prevention of methamphetamine use, through, at a minimum, public service messages that are based on research showing what is effective 

in substantially reducing such use among young people, including public service messages in both print and electronic media and on websites. 


ccoleman on PROD1PC71 with HEARING
15 

‘‘(3) AUTHORITY TO USE FUNDS FOR OTHER DRUG ABUSE UPON

CERTIFICATION THAT METHAMPHETAMINE ABUSE FELL DURING

FISCAL YEAR 2007.—With respect to fiscal year 2008 and any fiscal year thereafter, if the Director certifies in writing to Congress that domestic methamphetamine laboratory seizures (as 

reported to the El Paso Intelligence Center of the Drug Enforcement Administration) decreased by at least 75 percent 

from the 2006 level, the Director may apply paragraph (1)(A) 

for that fiscal year with respect to advertisements specifically 

intended to reduce the use of such other drugs as the Director 

considers appropriate. 

Page 213, line 7, strike ‘‘(k)’’ and insert ‘‘(l)’’. 

14. AN AMENDMENT TO BE OFFERED BY REPRESENTATIVE RENZI OF

ARIZONA, OR HIS DESIGNEE, DEBATABLE FOR 10 MINUTES

At the end of the bill, add the following new section (and conform 

the table of contents accordingly): 

SEC. 20. REPORT ON TRIBAL GOVERNMENT PARTICIPATION IN HIDTA 

PROCESS. 

(a) REPORT REQUIREMENT.—The Director of the Office of National 

Drug Control Policy shall prepare a report for Congress on the representation of tribal governments in the High Intensity Drug Trafficking Areas Program and in high intensity drug trafficking areas 

designated under that Program. The report shall include—

(1) a list of the tribal governments represented in the Program and a description of the participation by such governments in the Program; 

(2) an explanation of the rationale for the level of representation by such governments; and 

(3) recommendations by the Director for methods for increasing the number of tribal governments represented in the Program. 

(b) DEADLINE.—The report prepared under subsection (a) shall be 

submitted not later than 1 year after the date of the enactment of 

this Act. 

(c) DEFINITION.—In this section, the term ‘‘High Intensity Drug 

Trafficking Areas Program’’ means the program established under 

section 707 of the Office of National Drug Control Policy Reauthorization Act of 1998 (21 U.S.C. 1706). 

15. AN AMENDMENT TO BE OFFERED BY REPRESENTATIVE TERRY OF

NEBRASKA, OR HIS DESIGNEE, DEBATABLE FOR 10 MINUTES

Page 143, after line 11, insert the following: 

(1) Section 704(c)(2) is amended by inserting ‘‘and the head 

of each major national organization that represents law enforcement officers, agencies, or associations’’ after ‘‘agency’’. 

Page 143, line 12, strike ‘‘Section 704(c)(2)’’ and insert the following: 

(2) Section 704(c)(2) 

Æ 


ccoleman on PROD1PC71 with HEARING